RenovoRx
RNXT
12 hedge funds and large institutions have $758K invested in RenovoRx in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
60% more capital invested
Capital invested by funds: $473K → $758K (+$285K)
0.3% less ownership
Funds ownership: 3.4% → 3.1% (-0.3%)
14% less funds holding
Funds holding: 14 → 12 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NPT
Nixon Peabody Trust
Boston,
Massachusetts
|
+$92.6K |
| 2 |
HF
HRT Financial
New York
|
+$13.4K |
| 3 |
BlackRock
New York
|
+$5.77K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.28K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$113 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LBC
Lawrence B. Cohen
|
-$129K |
| 2 |
LFAS
Level Four Advisory Services
Dallas,
Texas
|
-$19.9K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$17.3K |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$14.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13K |
RNXT Hedge Fund Activity: Q4 2023 in Review
12 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q4 2023, worth a combined $758K — up 60% from $473K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of RNXT and 4 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Nixon Peabody Trust, opening a new position worth an estimated $92.6K. The largest seller was Lawrence B. Cohen, exiting entirely with an estimated $129K sold.
- 12 institutional investors held RenovoRx (RNXT) as of Q4 2023, down from 14 in Q3 2023.
- Funds reported $758K of RenovoRx stock for Q4 2023, up 60% quarter-over-quarter.
- 4 funds opened new RenovoRx positions in Q4 2023 and 6 closed out, a net change of -2 holders.
- The largest RenovoRx buyer in Q4 2023 was Nixon Peabody Trust, an estimated $92.6K added.
- The largest RenovoRx seller in Q4 2023 was Lawrence B. Cohen, an estimated $129K sold.
Based on aggregated 13F filings for Q4 2023.